BCL2L11 and non-small cell lung carcinoma: Collectively, our data demonstrated that combination of ABT-737 and erlotinib could induces tumor cells apoptosis, and shrinking the xenografts tumors produced by NSCLC cells expressing EGFR-mutant and harboring the BIM deletion polymorphism.